These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 22896987)

  • 1. [Iatrogenic lung diseases].
    Karoli NA; Rebrov AP; Roshchina AA; Steshenko RN; Bukiia AS
    Klin Med (Mosk); 2012; 90(4):70-2. PubMed ID: 22896987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung lesions in children with Crohn's disease presenting as nonresolving pneumonias and response to infliximab therapy.
    Krishnan S; Banquet A; Newman L; Katta U; Patil A; Dozor AJ
    Pediatrics; 2006 Apr; 117(4):1440-3. PubMed ID: 16585347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators.
    Feagan BG; Rochon J; Fedorak RN; Irvine EJ; Wild G; Sutherland L; Steinhart AH; Greenberg GR; Gillies R; Hopkins M
    N Engl J Med; 1995 Feb; 332(5):292-7. PubMed ID: 7816064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience of methotrexate in Crohn's disease: response, safety and monitoring of treatment.
    Parker R; Dixit A; Fraser A; Creed TJ; Probert CS
    Postgrad Med J; 2010 Apr; 86(1014):208-11. PubMed ID: 20354043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate.
    Laharie D; Zerbib F; Adhoute X; Boué-Lahorgue X; Foucher J; Castéra L; Rullier A; Bertet J; Couzigou P; Amouretti M; de Lédinghen V
    Aliment Pharmacol Ther; 2006 Jun; 23(11):1621-8. PubMed ID: 16696812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate in Crohn's disease: results of a randomized, double-blind, placebo-controlled trial.
    Arora S; Katkov W; Cooley J; Kemp JA; Johnston DE; Schapiro RH; Podolsky D
    Hepatogastroenterology; 1999; 46(27):1724-9. PubMed ID: 10430331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and tolerability of methotrexate for treating patients with Crohn's disease.
    Chande N; Abdelgadir I; Gregor J
    J Clin Gastroenterol; 2011 Aug; 45(7):599-601. PubMed ID: 21224737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.
    Feagan BG; Fedorak RN; Irvine EJ; Wild G; Sutherland L; Steinhart AH; Greenberg GR; Koval J; Wong CJ; Hopkins M; Hanauer SB; McDonald JW
    N Engl J Med; 2000 Jun; 342(22):1627-32. PubMed ID: 10833208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of methotrexate therapy for refractory Crohn's disease: a large single-centre experience.
    Suares NC; Hamlin PJ; Greer DP; Warren L; Clark T; Ford AC
    Aliment Pharmacol Ther; 2012 Jan; 35(2):284-91. PubMed ID: 22112005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced and iatrogenic infiltrative lung disease.
    Camus P; Bonniaud P; Fanton A; Camus C; Baudaun N; Foucher P
    Clin Chest Med; 2004 Sep; 25(3):479-519, vi. PubMed ID: 15331188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infiltrative lung disease due to noncytotoxic agents.
    Lock BJ; Eggert M; Cooper JA
    Clin Chest Med; 2004 Mar; 25(1):47-52. PubMed ID: 15062596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary functional disorders in ulcerative colitis and Crohn's disease].
    Sommer H; Schmidt M; Gruber KD
    Dtsch Med Wochenschr; 1986 May; 111(21):812-5. PubMed ID: 3698863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate in Crohn's disease: long-term efficacy and toxicity.
    Lémann M; Zenjari T; Bouhnik Y; Cosnes J; Mesnard B; Rambaud JC; Modigliani R; Cortot A; Colombel JF
    Am J Gastroenterol; 2000 Jul; 95(7):1730-4. PubMed ID: 10925976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C; Beau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):153-7. PubMed ID: 18343615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological pulmonary changes on an iatrogenic basis.
    Scheffer E
    Acta Tuberc Pneumol Belg; 1979; 70(3-4):191-201. PubMed ID: 262934
    [No Abstract]   [Full Text] [Related]  

  • 16. Vulvar manifestations of Crohn's disease.
    Foo WC; Papalas JA; Robboy SJ; Selim MA
    Am J Dermatopathol; 2011 Aug; 33(6):588-93. PubMed ID: 21697699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
    Nathan DM; Iser JH; Gibson PR
    J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations.
    Barreiro-de Acosta M; Domínguez-Muñoz JE; Núñez-Pardo de Vera MC; Lozano-León A; Lorenzo A; Peña S
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):73-8. PubMed ID: 17206080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there any remaining role for methotrexate for Crohn's disease?
    Korelitz BI
    Dig Liver Dis; 2003 Sep; 35(9):610-1. PubMed ID: 14563181
    [No Abstract]   [Full Text] [Related]  

  • 20. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.
    Duijvestein M; Vos AC; Roelofs H; Wildenberg ME; Wendrich BB; Verspaget HW; Kooy-Winkelaar EM; Koning F; Zwaginga JJ; Fidder HH; Verhaar AP; Fibbe WE; van den Brink GR; Hommes DW
    Gut; 2010 Dec; 59(12):1662-9. PubMed ID: 20921206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.